• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Catalog Number 8065977763
Device Problem Contamination /Decontamination Problem (2895)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/08/2020
Event Type  Injury  
Manufacturer Narrative
The product was not returned for analysis.Monarch complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.There have been 12 similar complaints in this lot.(b)(4).
 
Event Description
A physician reported that a foreign material was found to be adhered to the backside of the intraocular lens (iol) after implanting; this was noted in three cases.The foreign material was able to be removed by aspirating with the irrigation and aspiration.The surgery was completed and the lenses remain implanted.There are multiple reports for this event, this represents the cartridge for patient (b)(6) and additional reports will be filed.
 
Manufacturer Narrative
The used cartridge complaint sample was not returned.A video was provided.The cartridge preparation was not shown.Viscoelastic amount could not be determined.The lens was loaded with narrow tip forceps.A different set of forceps was used to rapidly advance the lens in the cartridge.The cartridge tip was inserted into the incision.The lens was rapidly advanced from mid-nozzle into the eye.After the lens unfolds, a strip of material was observed on the right side of the posterior surface.The material was removed with the i/a tip.The lens remained implanted.The associated lens model/diopter indicated is qualified for use with the cartridge.A non-qualified handpiece/viscoelastic combination was indicated.Root cause: the root cause for the reported foreign material could not be determined.The used cartridge was not returned.No determination can be made without physical evaluation of the complaint sample.The provided video was reviewed.A strip of material was observed on the posterior surface.Based on the review of the provided video, the observed material may have been internal coating material from the cartridge.A non-qualified handpiece/viscoelastic combination was indicated.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
MDR Report Key10657740
MDR Text Key211004403
Report Number1119421-2020-01434
Device Sequence Number1
Product Code MSS
Combination Product (y/n)N
PMA/PMN Number
K063155
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8065977763
Device Lot Number32751148
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/18/2020
Initial Date FDA Received10/09/2020
Supplement Dates Manufacturer Received10/20/2020
Supplement Dates FDA Received11/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AE-9036SP; OPEGAN; SN60WFA205, ACRYSOF SP NATURAL IQ, HWV
Patient Outcome(s) Required Intervention;
-
-